A phase II trial of neoadjuvant methotrexate, vinblastine, doxorubicin, and cisplatin in the treatment of patients with locally advanced breast carcinoma

Overview of attention for article published in Cancer (0008543X), October 2000

Altmetric Badge

Mentioned by

patent: 1 patent

Readers on

mendeley: 30 Mendeley

So far, Altmetric has seen 1 patent that references this research output.

Methods of predicting responsiveness to chemotherapeutic agents and selecting treatments

Grant US-8133692-B2

United States of America

This page shows the most recent patents that mention this research output. Click here to find out how to access more activity.